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ABSTRACT 
 
MicroRNAs are well established regulators of Inflammatory Bowel Disease (IBD), 
such as Crohn’s disease (CD) and ulcerative colitis (UC). Furthermore, 
gasotransmitters including nitric oxide (NO), carbon monoxide (CO) and 
hydrogen sulphide (H2S) also seem to play important role in this disease 
pathogenesis. In the present study, we aimed to investigate the relationship 
between microRNAs and gasotransmitters in colitis. Male Wistar rats were 
administered 2, 4, 6-trinitrobenzenesulphonic acid (TNBS, 10 mg/0.25 ml in 
50% ethanol) rectally to induce colitis. For the purpose of comparison, we 
observed miRNA expressions by nanoString nCounter® miRNA Expression 
Assay and measured the activities and expressions (by Western blot) of the 
enzymes responsible for gasotransmitter synthesis. In total, 228 miRNA were 
screened and from these 94 showed upregulation and 63 were downregulated. 
We found several miRNAs (miR-26a, miR-200a, miR-200c, miR-21, miR-222, 
miR-101, miR-28, miR-132, miR-7, miR-141, let-7, miR-196a, miR-30 and miR-
186) that might have an effect on gasotransmitter pathways. This study proved 
that there are important interactions between gasotransmitters and microRNAs 
in TNBS-induced rat colitis. Our results are presumably important in IBD 
diagnostics, pathogenesis modelling and could be a starting-point to further 
investigations. 
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INTRODUCTION 
 
Inflammatory bowel disease (IBD) is identified as an 
immune-mediated disease with autoimmune phenomenon, 
which may expand to the global gastrointestinal tract (GI) 
(Wen and Fiocchi, 2004, Chen et al., 2014). Several 
subtypes of IBD were described with particular regard to 
the most common forms, Crohn’s disease (CD) and 
ulcerative colitis (UC) (Archanioti et al., 2011). Despite 
intensive research on IBD currently, the pathogenesis of 
this disease is still unknown, although several factors have 
been revealed to contribute to its development, including 
genetic, environmental, immunological and most recently, 
epigenetic factors. Of these, research on microRNAs 
(miRNAs) seems to be a new promising area with the 
potential of being relevant biomarkers for IBD diagnosis or 
targets for future treatments (Coskun et al., 2012).  
MicroRNAs are small (18 to 24 nucleotide), non-coding, 
evolutionary conserved RNA molecules with the ability to 
regulate mRNA expression levels through transcriptional 
repression or degradation of their target mRNA (Kalla et 
al., 2015). The miRNA mediated gene expression 
regulation is crucial in several physiological processes (Su 
et al., 2013; Varga et al., 2013), including cell cycle, 
differentiation,     apoptosis    ( Farago   et   al., 2011 ),    cell 
homeostasis, stress response (Iborra et al., 2013, Varga et
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al., 2013, 2014), immune development and response (Su et 
al., 2013) and numerous pathological conditions such as 
cancer development, stroke and inflammatory processes 
(Sonkoly and Pivarcsi, 2009). 
miRNAs are described recently as important 
constituents of the innate and adaptive immune system 
and differential expressions of microRNAs are associated 
with several immune-mediated diseases such as psoriasis, 
arthritis and IBD (Dalal and Kwon, 2010). It has been 
shown that miRNAs are expressed differently in the 
peripheral blood and intestinal tissues of patients with 
both CD and UC. Furthermore, discrepancies can be 
observed in active disease stages as well (Takagi et al., 
2010; Wu et al., 2011). 
Gasotransmitters, such as nitric oxide (NO), carbon 
monoxide (CO) and hydrogen sulphide (H2S) are signaling 
molecules with key functions in cell physiology (Mustafa et 
al., 2009). It has been shown that gasotransmitter 
synthesizing enzymes exhibit different activities and 
expression levels in colitis (Szalai et al., 2014), indicating 
that these molecules might be important in IBD 
development. Inducible nitric oxide synthase (iNOS) and 
constitutive nitric oxide synthase (cNOS) endothelial 
(eNOS) and neuronal (nNOS), produces NO, the first 
identified gasotransmitter from L-arginine in response to 
pro-inflammatory cytokines. Both enzymes’ expressions 
have been shown to be upregulated in the intestinal 
epithelium and inflamed colonic mucosa in IBD (Dhillon et 
al., 2014; Szalai et al., 2014).  
Carbon monoxide (CO) is the second described 
gasotransmitter with physiological vasorelaxant 
properties (Wang et al., 1997). CO is generated 
endogenously through the biodegradation of heme, which 
catalyzed by heme oxygenase (HO) enzymes. In this 
reaction, besides CO, biliverdin and free Fe2+ also arise, 
which are responsible for the antioxidant and 
antiapoptotic effects of HO. There are three isoforms of the 
HO enzyme, HO-1 (inducible form, also known as hsp32), 
HO-2 (constitutive isoform) and HO-3 (Ryter and Choi, 
2016). These isoforms are encoded by HMOX-1,-2,-3 genes 
in human and Hmox-1,-2,-3 genes in rat (Kutty et al., 
1994). Several studies reported that CO and the HO 
enzymes play important roles in inflammatory conditions 
through their anti-inflammatory effects (Hegazi et al., 
2005; Sheikh et al., 2011), thus, CO/HO system is becoming 
one of the main targets in IBD research. 
A recently discovered gasotransmitter is H2S, produced 
from L-cystein through two main pathways in the colon, a 
pyridoxal-5’-phosphate (P5P) dependent manner, 
containing two enzymes, cystathionine β-synthase (CBS) 
and cystathionine γ-lyase (CSE) and another pathway 
which operates with an intermediate (3-
mercaptopyruvate) and requires cysteine 
aminotransferase (CAT) and a mitochondria localized 
enzyme, mercaptopyruvate sulfurtransferase (3MST) (Guo 
et al., 2012; Flannigan et al., 2013).  
H2S is essential in various physiological processes 
including neuromodulation (Abe and Kimura, 1996), 
vasorelaxation, colon contractility (Teague et al., 2002), 
long term potentiation (LTP) (O'Dell et al., 1991), 
apoptosis and ulcer healing (Wallace et al., 2009). The 
exact role of H2S in IBD is controversial. It is reported that 
H2S is elevated in IBD, but its role in this disease is 
complex and depends on several factors, such as the model 
used in the investigation, whether the inflammation is 
acute or chronic and the time of the administration of H2S 
donors or inhibitors (Whiteman and Winyard, 2011). 
In the present study, we aimed to investigate the 
different expressions of miRNAs, along with the changes of 
gasotransmitter synthesizing enzyme activities or altered 
expressions in animal model of colitis. In this context, we 
objected to identify the link between differentially 
expressed miRNAs and the changes in enzyme activities 
and expressions to propose a novel therapeutic target in 
IBD research. 
 
 
 
MATERIALS AND METHODS 
 
Animals 
 
All manipulations were performed in accordance with the 
standards of the European Community guidelines on the 
care and use of laboratory animals and was approved by 
the Institutional Ethics Committee at the University of 
Szeged. 
Male Wistar rats (180 to 220 g) were housed in groups. 
Food was withdrawn overnight before induction of colitis; 
otherwise, the animals had access to food and drinking 
water ad libitum throughout the experiments. The animal 
care and research protocols were in accordance with the 
guidelines of the University of Szeged. 
 
 
Experimental design 
 
The animals were randomly divided into three groups: 
absolute control (no treatment), vehicle (50% ethanol 
(EtOH)) and TNBS (10 mg/0.25 ml in 50% ethanol). 
Animals were fasted for 24 h before treatment. On the first 
day of experiment colitis was induced by 2, 4, 6-
trinitrobenzenesulphonic acid (TNBS; single injection 10 
mg in 0.25 ml of 50% ethanol). The intracolonic 
administration of TNBS was performed with an 8 cm long 
plastic catheter under transient ether anaesthesia, while 
the control groups did not receive any treatment. Three 
days after the induction of colitis the animals were 
sacrificed and the distal 8 cm portion of the colon 
dissected, longitudinally opened, gently rinsed with ice-
cold physiological saline and photographed for the 
determination of macroscopic colonic inflammatory 
damage. The colon was weighed and divided    into   
longitudinal   segments   to   be  used for further molecular  
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and biochemical analyses. 
 
 
Heme oxygenase activity 
 
Heme oxygenase activity was assessed by measuring 
bilirubin formation with slight modifications as described 
by Tenhunen et al. (1968). The colon segment was 
homogenized (Ultra-turrax T25; 13.500/s; twice for 30 s) 
in ice-cold 10 mM N-[2-hydroxyethyl] piperazine-N’-[2-
ethanesulfonic acid] (HEPES, Sigma-Aldrich), 32 mM 
sucrose (Sigma-Aldrich), 1 mM dithiothreitol (DTT, Sigma-
Aldrich), 0.1 mM EDTA, 10 μg/ml soybean trypsin 
inhibitor (Sigma-Aldrich), 10 μg/ml leupeptin (Sigma-
Aldrich) and 2 μg/ml aprotinin (Sigma-Aldrich); pH 7.4. 
The supernatant was collected by centrifugation for 30 
min at 20.000 g at 4°C. Incubation was carried out in the 
dark at 37°C for 60 min with the reaction mixture 
containing the following ingredients in a final volume of 
1.5 ml: 2 mM glucose 6-phosphate (Sigma-Aldrich), 0.14 
U/ml glucose 6-phosphate dehydrogenase (Sigma-
Aldrich), 15 μM heme, 150 μM β-nicotinamide adenine 
dinucleotide phosphate (β-NADPH, Sigma-Aldrich), 120 
μg/ml rat liver cytosol as a source of biliverdin reductase, 
2 mM MgCl2, 100 mM potassium phosphate buffer and 150 
μl supernatant. The reaction was stopped by placing the 
samples on ice. The bilirubin formed was calculated from 
the difference between optical densities obtained at 460 
and 530 nm. One unit of heme oxygenase activity was 
defined as the amount of bilirubin (nmol) 
produced/hour/mg protein. 
 
 
Nitric oxide synthase activity 
 
Nitric oxide synthase activity was determined by 
quantifying the conversion of [14C]-radiolabelled L-
arginine to citrulline by a previously described method 
with some minor modifications (Boughton-Smith et al., 
1993). A segment of colon was homogenized as described 
for HO activity. Homogenates were centrifuged for 30 min 
at 20.000 g at 4°C. Samples (40 µl) were incubated for 10 
min at 37°C in 100 µl of assay buffer [50 mM KH2PO4, 1.0 
mM MgCl2, 50 mM L-valine, 0.2 mM CaCl2, 1.0 mM DTT, 1.0 
mM L-citrulline, 15.5 nM L-arginine, 30 µM flavin adenine 
dinucleotide, 30 µM flavin mononucleotide, 30 M 
tetrahydro-L-biopterin dihydrochloride, 450 µM β-NADPH 
and 12 pM of [14C]-L-argininemonohydrochloride (all from 
Sigma-Aldrich). The reaction was terminated by the 
addition of 0.5 ml of 1:1 (v/v) suspension of ice-cold 
DOWEX (Na+-form) in distilled water. The mixture was 
resuspended with the addition of 850 µl of ice-cold 
distilled water. The supernatant (970 µl) was removed and 
radioactivity determined by scintillation counting. 
Calcium-dependency of the NOS activity was determined 
by the addition of 10 µl of ethylene glycol-bis (β-
aminoethyl ether) tetraacetic acid (EGTA; 1 mM, Sigma-
Aldrich). NOS activity was confirmed by inhibition with 10 
µl of N-nitro-L-arginine-methylester (LNNA; 3.7 mM, 
Sigma-Aldrich). Inducible NOS was defined as the citrulline 
formation that was inhibited by LNNA and not EGTA. The 
constitutive NOS activity was calculated from the 
difference between citrulline formation that was inhibited 
by EGTA and the total activity. As the nature of the 
constitutive isoform (eNOS or nNOS) was not determined, 
this activity is referred to as cNOS. NOS activity was 
expressed as pmol/min/mg protein. 
 
 
CBS and CSE Western blotting 
 
Western blot analysis was used to determine colonic 
expressions of CBS and CSE in samples from rats with 
colitis and healthy controls. Colonic tissue was processed 
and blots prepared as previously described. Proteins were 
separated on 4 to 20% gradient polyacrylamide gels. 
Rabbit polyclonal anti-CSE (1:200), anti-CBS (1:800) were 
used. Enzyme expression was visualized using a secondary 
anti-rabbit IgG antibody conjugated to horseradish 
peroxidase (1:1000) and an enhanced chemiluminescence 
detection kit on a Chemi-doc gel imaging system (Bio-Rad). 
The intensity of the bands was determined and analyzed 
using ImageLab 2.0 software (Bio-Rad). The expression of 
each enzyme was normalized to the expression of β-actin. 
 
 
miRNA expression profile assay by nanoString 
nCounter® 
 
For the microRNA purification 40 mg tissue was used. 
Purification of microRNA was done with the High Pure 
miRNA Isolation Kit (Roche, Cat. no. 05080576001) as 
previously described with slight modifications (Coskun et 
al., 2013). Briefly: tissue was lysed with 400 μl 20% 
Binding Buffer, 320 μl Binding Enhancer (Roche) was 
added, mixed and loaded onto the filter columns (Roche). 
Next, the filters were washed in two steps with 500 and 
300 μl of Washing Buffer (Roche), then, the RNA was 
eluted by adding 100 μl Elution Buffer (Roche). All other 
steps were done according to the manufacturer's 
recommendations. The quality and quantity was assessed 
spectrophotometrically (Nanodrop, USA) and with 2100 
Bioanalyzer (Agilent). 
MicroRNA (150 ng) from the tissue was analyzed using 
the nanoString nCounter Analysis System. All procedures 
related to miRNA quantification including sample 
preparation were carried out as recommended by 
nanoString Technologies. The detailed protocol for 
microRNA analysis (sample preparation, hybridization, 
detection and scanning) was carried out according to the 
manufacturer’s recommendation and is available at 
http://www.nanostring.com/products/miRNA  (Farago  et  
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Figure 1: (A) Tissue damage parameter (lesion) manifested severe inflammation of 2, 4, 6 trinitrobenzenesulphonic acid 
(TNBS)- induced colitis in rats. (n=7-10; mean ± SEM; * Compare to the control group, *p<0.05, **p<0.01). Illustrative pictures 
from (B) absolute control, (C) ethanol (EtOH) and (D) TNBS group animal’s colon. 
 
 
al., 2011). 
 
 
Data representation and statistical analysis 
 
Results of the lesion, the activity of HO, cNOS, iNOS and the 
expression of CBS and CSE are shown as mean ± S.E.M; 
statistical comparisons were performed by two tailed 
Student’s t-test. The significance of the differences 
between samples was determined by applying the 
Newman-Keuls test using GraphPad Prism for Windows. In 
all statistical comparisons, a probability (*) value of less 
than 0.05 was considered significant. 
 
 
RESULTS 
 
The severity of lesions in treated rat colon 
 
The severity of lesions in each group was determined. In 
the control group, colons were healthy, normal with no 
ulcers found. Figure 1 shows the severity of lesions in the 
EtOH treated group are significantly increased, but in the 
TNBS group the lesions were much more pronounced. 
 
 
miRNA expression changes in TNBS treated rat colon 
 
The changes in the expression of 228 miRNAs in TNBS 
colitis rat colons with digital approach, which captures and 
counts individual miRNA transcripts was screened 
(Mestdagh et al., 2014). 94 upregulated and 63 
downregulated miRNAs were found and the significantly 
changed miRNAs was classified into five clusters, 
according to their targets and regulated pathways based 
on the current literature. Tables 1 and 2 present miRNA 
clusters and their fold change. 
 
 
Changes in colonic HO activity in TNBS- induced colitis 
 
Heme oxygenase enzyme showed increased enzyme 
activity in the 50% EtOH and the TNBS group as well. Our 
results were significant in both groups; EtOH (0±0.1 vs 
0.2±0.02 compared to control; p<0.05), but we measured 
much higher HO enzyme activity in the TNBS group (0±0.1 
vs 4.7±0.3 compared to control; p<0.001; 0.2±0.02 vs 
4.7±0.3 compared to EtOH; p<0.001) (Figure 2). 
 
 
The changes in NOS activities 
 
Both iNOS and cNOS enzyme activities in all three groups 
were measured. It is clearly shown in our results that iNOS 
activity was elevated in the 50% EtOH group and it was 
three-folds higher and significant in TNBS group only 
(49.3±19.9 vs 158±19.8 compared to control; p<0.01) 
(Figure 3a). The 50% EtOH and the TNBS treatment also 
significantly decreased cNOS activity (1428±114 vs. 
872±76,  control  vs  EtOH,  p<0.01;  1428±114 vs. 571±89, 
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Table 1: Upregulated miRNA expression changes in TNBS colitis rat colon samples (fold 
change: TNBS compared to control). 
 
Upregulated miRNAs Fold change 
IBD associated   
miR-141 2.83 
miR-200b 2.91 
miR-223 2.51 
miR-320 3.50 
miR-126 2.07 
 
Proinflammatory effects  
miR-127 5.70 
miR-134 3.74 
miR-429 2.98 
miR-628 4.27 
miR-186 2.07 
miR-494 4.03 
miR-674-5p 2.90 
miR-222 3.38 
miR-101b 5.81 
 
Antiinflammatory effects  
miR-1224 4.34 
miR-511 5.33 
let-7i 2.02 
miR-568 3.97 
miR-30a 2.28 
miR-122 1.58 
 
Tumor suppressors   
miR-455 2.10 
miR-30e 3.19 
miR-337 9.82 
miR-615 2.28 
miR-136 5.48 
miR-465 3.05 
miR-144 2.75 
miR-451 3.08 
miR-30b-3p 2.82 
miR-376a 3.31 
miR-490 2.41 
miR-125a-3p 2.92 
miR-632 2.04 
miR-196a 2.31 
miR-324-3p 3.06 
miR-544 3.25 
miR-200c 2.76 
miR-7a 3.99 
miR-665 6.86 
 
oncomiRs   
miR-652 2.15 
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Table 1 contd: Upregulated miRNA expression changes in TNBS colitis rat colon 
samples (fold change: TNBS compared to control). 
 
miR-501 2.81 
miR-532-5p 2.60 
miR-362 3.71 
miR-632 2.04 
miR-196a 2.31 
miR-324-3p 3.06 
miR-544 3.25 
miR-200c 2.76 
miR-450a 3.50 
miR-331 2.04 
miR-201 2.26 
miR-7a  3.99 
miR-369-5p 2.35 
 
AngiomiRs  
miR-342-5p 2.20 
miR-376b-5p 3.87 
miR-350 2.35 
miR-101a 4.98 
 
 
 
control compared to TNBS, p<0.001) (Figure 3b). 
 
 
CBS and CSE enzymes expression changes 
 
By measuring the expression changes of CBS and CSE 
enzymes using Western blotting, we observed diminished 
expression levels (CBS: EtOH: 2022,674±137.95, TNBS: 
1602.917±337.926 vs control: 2917.169±123.9; CSE: 
EtOH: 7320.431±506.35, TNBS: 5835.478±497.34, 
compared to control: 9370±752.217) in the treated groups 
as compared to the control and the expression changes 
were significant only in the TNBS group (p<0.05) (Figure 
4a and b). 
 
 
DISCUSSION 
 
The aim of the present study was to determine the 
relationship between the differentially expressed miRNAs 
and gasotransmitter synthesizing enzymes in a TNBS-
induced colitis model. Specifically, we screened 228 
miRNA’s expression changes and the gasotransmitter 
synthesizing enzyme activities and expression changes 
were measured in parallel for comparison. 
Inflammatory bowel diseases, such as Crohn’s disease 
and ulcerative colitis are chronic immune-related gastro-
intestinal disorders. Epidemiological studies on IBD 
showed that this disease is widespread particularly in 
Northern and Western Europe and North America (Ponder 
and Long, 2013). However, much lower rates of incidence 
are demonstrated in areas of Africa, South America and 
Asia, suggesting that westernization might be a special risk 
factor for developing IBD in susceptible individuals (Ye et 
al., 2015). Owing to its worldwide occurence and the fact 
that the accurate pathomechanism is still unknown, IBD is 
one of the most researched areas presently. Furthermore, 
the diagnosis and the exact characterization of these 
diseases are cumbersome and unresolved because there is 
no reliable and existence of non-invasive diagnostic test.  
Numerous studies demonstrated that IBD is associated 
with the differentially expressed genes which contribute to 
immune responses and healing progression as well (Wu et 
al., 2010). In recent years, a new potential area of 
diagnostics was revealed, utilizing the differentially 
expressed miRNAs, called miRNA profiles, which seems to 
be a novel diagnostic marker (Fisher and Lin, 2015; 
Schaefer et al., 2015). It is becoming increasingly clear that 
miRNAs, gasotransmitter synthesizing enzymes and the 
produced gasotransmitters have a crucial role in this 
disease as well. 
The differential expression of microRNAs and their role 
in IBD have not been extensively studied, but it is a 
promising new area of research. In our present study, we 
screened 228 miRNAs expression changes in TNBS 
induced rats colitis, and found 94 upregulated and 63 
downregulated miRNAs. The differentially expressed 
miRNAs were classified according to their target mRNAs 
and affected pathways based on current evidence. Five 
clusters were identified: IBD associated miRNAs, 
oncomiRs, tumor suppressors, miRNAs which have 
proinflammatory, or antiinflammatory effects and 
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Table 2: Downregulated miRNA expression changes in TNBS colitis (fold change: TNBS 
compared to control). 
 
Downregulated miRNAs Fold change 
IBD associated   
miR-29a 0.18 
miR-132 0.34 
miR-19a 0.56 
miR-21 0.64 
miR-150 0.14 
miR-191 0.09 
miR-107 0.44 
miR-199a-5p 0.23 
miR-143 0.09 
 
Proinflammatory effects  
miR-23b 0.39 
miR-146a 0.35 
miR-16 0.27 
miR-139-5p 0.31 
 
Antiinflammatory effects  
miR-19b 0.64 
miR-23a 0.35 
miR-93 0.63 
 
Tumor suppressors   
miR-26a 0.30 
miR-29b 0.06 
miR-29c 0.12 
miR-30c 0.13 
miR-204 0.25 
miR-133a 0.23 
miR-26b 0.61 
miR-290 0.41 
miR-203 0.45 
miR-28 0.39 
miR-215 0.07 
miR-192 0.18 
miR-148b-3p 0.39 
miR-411 0.55 
miR-199a-3p 0.10 
miR-152 0.21 
miR-30d 0.22 
miR-145 0.29 
miR-324-5p 0.46 
miR-154 0.54 
miR-205 0.29 
miR-15b 0.05 
 
oncomiRs   
miR-24 0.25 
miR-183 0.18 
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Table 2 Contd: Downregulated miRNA expression changes in TNBS colitis (fold change: TNBS 
compared to control). 
 
miR-103 0.22 
miR-151 0.30 
miR-1249 0.64 
miR-96 0.45 
miR-106b 0.30 
miR-425 0.18 
miR-423 0.55 
miR-17-5p 0.35 
miR-130b 0.53 
miR-342-3p 0.07 
 
AngiomiRs  
let-7d 0.17 
miR-130a 0.14 
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Figure 2: Heme oxygenase (HO) enzyme activity changes in ethanol (EtOH) alone and 2, 4, 6 
trinitrobenzenesulphonic acid (TNBS)- induced colitis. HO enzyme activity was determined by 
measurement of bilirubin formation (n=4-10; mean ± SEM; # Compare to the control group, * compare 
to the EtOH group; *, # p<0.05, **, ## p<0.01, ***, ### p<0.001). 
 
 
(Tables 1 and 2). 
Several miRNAs were found to be relevant contributors 
to IBD pathogenesis. For instance, Schaefer et al. (2015) 
found that in saliva, blood and intestinal samples from IBD 
patients,  that  miR-19a,  miR-21,  miR-31,  miR-101,   miR- 
146a and miR-375 might be diagnostic markers in IBD. In 
our study, we found the same changes in miR-21, miR-101 
and miR-146a expressions, but we did not observe 
significant changes in miR-19a, miR-31 and miR-375 
expressions. Wu et al. (2010) measured miRNAs in IBD 
patients and found four miRNAs to be significantly over-
expressed; miR-16, miR-21, miR-223 and miR-594. These 
results do not completely agree with our findings, because 
we found miR-16 and miR-21 to be downregulated, while 
we have not seen a significant change in miR-594. This 
discrepancy might be interpreted by the different species, 
because Wu et al. (2010) used human samples and we 
used rat samples for our investigations. Furthermore, 
Zahm et al. (2014) analyzed the miRNA expression 
changes in young UC and CD patients and found several 
miRNAs, miR-192, miR-194, miR-21 and miR-142-3p that 
were upregulated with the most abundant expression 
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Figure 3: Colon tissue inducible nitric oxide synthase (iNOS) and constitutive nitric oxide synthase (cNOS) activities 
measured by enzyme conversion. Bar chart (A) representing iNOS activity, and chart (B) representing cNOS activity. 
Groups: control (no treatment); ethanol (EtOH) and 2, 4, 6-trinitrobenzenesulphonic acid (TNBS). Values are 
represented as means ± S.E.M. for n = 4-10; * Compared to the control group, # compare to the ethanol group; *, # 
p<0.05, **, ## p<0.01). 
 
 
 
 
Figure 4: The hydrogen sulphide (H2S) producing enzymes (cystathionine β-synthase (CBS), and cystathionine γ-lyase (CSE)) 
expression changes by Western Blotting in treatment with ethanol (EtOH) or 2,4,6-trinitrobenzenesulphonic acid (TNBS) are 
demonstrated in (A) and (B) panel (n=4-10; mean ± SEM; * Compared to the control group, # compare to the ethanol group; *,# 
p<0.05, **, ## p<0.01,***, ### p<0.001). 
 
 
changes in miR-21 and 142-3p.  
A growing body of research indicates that 
gasotransmitters have pivotal roles in IBD pathogenesis 
and disease outcome as well. For example, Aoi et al. (2008) 
demonstrated that administration of L-NAME, a specific 
inhibitor of NO production, exacerbated DSS-induced 
colitis, proposing the protective role of NO in colitis. In 
turn, application of NO donors such as NOR-3 and 
NONOates, aggravate DSS-colitis as well, suggesting that 
both low and excessive levels of NO worsened colitis 
(Yoshida et al., 2000). It is also suggested that 
pharmacological induction of HO-1 expression and 
activation or administration of CO donors can significantly 
attenuate experimental colitis (Erbil et al., 2007; Uddin et 
al., 2013). Fukuda et al. (2014) applied CORM-3 as a CO 
donor in TNBS- treated mice and described a significant 
reduction in the inflammatory response compared to TNBS 
control mice, which received an inactive form of CORM-3. 
Furthermore, Takagi et al. (2010) found that inhaled CO in 
low concentrations (200 ppm) also impacts the 
antiinflammatory process with a significant inhibition of 
colonic damage and decreased levels of TNF-α. Moreover, 
several studies reported the ability of H2S to enhance ulcer 
healing. Of these, Wallace et al. (2007) measured a high 
level of H2S in the reepitalization zone of the colonic ulcers 
which led to enhanced healing of the damaged colonic 
section. Wallace et al. (2010) also demonstrated in 
iodocetamide-induced murine colitis, that treatment with
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Figure 5: miRNAs which might responsible for the changes in gasotransmitters synthesizing enzymes expressions and 
activities. iNOS: inducible nitric oxide synthase; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; Myd88: 
myeloid differentiation primary response gene 88; IRAK-1: interleukin-1 receptor-associated kinase-1; SIRT1: sirtuin1; MKP-
1: map kinase phosphatase-1; JNK: c-Jun N-terminal kinases; AP1: activator-protein 1; cul3: cullin 3; Nrf2: nuclear factor 
erythroid 2-related factor; Keap1: Kelch-like ECH-associated protein-1; CSE: cystathionine-γ-lyase, cNOS: constitutive nitric 
oxide synthase, eNOS: endothelial nitric oxide synthase, nNOS: neuronal nitric oxide synthase, HO: heme oxygenase 
 
 
H2S donors,  such  as Lawesson’s Reagent or NaHS, cause 
amarked decrease in the severity of colitis. To test the 
effects of H2S in DSS-induced colitis, Hirata et al. (2011) 
administered a CSE inhibitor, DL-propargylglycine (PAG) 
and they found that this procedure worsened colitis. 
In our work, gasotransmitter synthesizing enzyme 
activities were increased the case of iNOS and HO enzymes 
in TNBS-treated rats, while the cNOS enzyme showed 
decreased activity. There are several studies which are in 
line with our findings (Yue et al., 2001); they showed that 
TNBS colitis increased the activity of iNOS enzyme with a 
concomitant protective effect. Wang et al. (2008) reported 
that HO-1 activity increased after the rectal induction of 
colitis by TNBS enema. Furthermore in our previous study, 
we showed the same changes about HO activity in the 
same animal model and our results pointed out that the 
HO-1 activity increased very rapidly and dramatically in 
the colon after TNBS treatment. The expression changes in 
CSE and CBS enzymes are controversial. In our study, in 
accordance with Wallace et al. (2009), the H2S synthesizing 
CSE and CBS expressions were reduced in the treated 
groups and unlike others we measured a significant 
reduction in the TNBS group. Other investigations showed 
that H2S producing enzyme expressions were enhanced in 
inflammation. For instance, Flannigan et al. (2013) and 
Distrutti et al. (2006) found an elevated expression of this 
enzyme in inflamed mucosa compared to healthy colon. 
Furthermore, Hirata et al. (2011) showed a time-
dependent increase in CSE and CBS expression, but they 
did not measure significant change at day 3 of their 
experiment as compared to day 0. 
In the present study we demonstrated for the first time 
that there might be relationships between 
gasotransmitters and microRNAs in IBD. Our results 
suggest that miRNAs are differentially expressed in TNBS- 
induced colitis and there are several miRNAs (miR-26a, 
miR-21, miR-222, miR-200a, miR-200c, miR-101, miR-28, 
miR-132, miR-7, miR-141, Let-7, miR-196a, miR-186 and 
miR-30) which might regulate gasotransmitter 
synthesizing enzyme mRNAs (Figure 5). 
We also found out that the downregulated expression of 
miR-26a might elevate iNOS activity. Zhu et al. (2013) 
demonstrating that iNOS is a direct target for miR-26a, 
thus, suppress its expression. In our TNBS- induced colitis 
colon samples, the miR-26a showed downregulated 
expression, thus, iNOS might be able to increase. It  was
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also observed  that  nuclear  factor kappa-light-chain 
enhancer of activated B cells (NF-κB), a transcription 
factor, induces the expression of iNOS enzyme. miR-21 
alleviates the expression levels of myeloid differentiation 
primary response gene 88 (MyD88) and interleukin-1 
receptor-activated kinase (IRAK-1), which are well known 
regulators of NF-κB  (Xu et al., 2014). In our study, miR-21 
showed downregulated expression, which means that 
MyD88 and IRAK-1 are not repressed, thus, it might 
contribute to an increase in NF-κB and iNOS expression. 
Furthermore, it is also suggested that MAP kinase 
phosphatase-1 (MKP-1) is a target for miR-101 and the 
increased expression of miR-101 is associated with an 
elevated level of MKP-1. The upregulated MKP-1 is able to 
inhibit p38 and c-Jun N-terminal kinase (JNK), which 
allows an increase of activator protein 1 (AP1) and thus 
iNOS expression (Gao et al., 2014). 
We suggest that three miRNAs (miR-200a, miR-200c and 
miR-222) regulate the eNOS and nNOS enzymes (also 
termed as cNOS). Evangelista et al. (2013) found that 
upregulation of miR-222 decreases eNOS enzyme. 
Furthermore, miR-200a and miR-200c target the sirtuin 1 
(SIRT1) 3’ UTR sequence and thus, contribute to a 
decrease in SIRT1 levels. SIRT1 was found to upregulate 
eNOS enzyme’s expression, but miR-200a and miR-200c 
seems to prevent this effect through the initiation of SIRT1 
mRNA degradation (Triggle et al., 2012, Carlomosti et al., 
2017). In addition, the miR-200a and miR-200c induced 
repression of SIRT1 might contribute to the upregulation 
of the iNOS enzyme as well through NF-κB (Yamakuchi, 
2012). 
HO-1 is induced as a protective mechanism against 
colonic oxidative damage. Hence, induction of HO-1 might 
have a potential role in the management of colitis. Several 
transcription factors are responsible for regulation of HO 
enzymes. One of these is the nuclear factor erythroid 2-
related factor 2 (Nrf2) which is repressed by Kelch ECH 
associating protein 1 (Keap1) (Reichard et al., 2007) and 
ubiquitilated by cullin 3 (cul3) (Kim et al., 2014) is able to 
attach to ARE (antioxidant response element) sequences, 
thus, inducing HO-1 expression (Reichard et al., 2007). We 
found several miRNAs, which appears to have an effect on 
HO-1 activation or repression. We suggest that several 
miRNAs contribute to an increase in Nrf2 and thus, HO-1 
expression according to other investigator’s studies: miR-
200a (Eades et al., 2011), miR-7 (Kabaria et al., 2015), 
miR-141 (Shi et al., 2015), which target the 3’ UTR 
sequence of Keap1. Furthermore, cul3, which is also 
responsible for the inhibition of Nrf2 is inhibited by the 
increased expression of miR-101 and may contribute to 
increased HO-1 expression (Schaefer et al., 2015). Another 
pathway that regulates HO expression is mediated by 
Bach1, which is responsible for tonic repression of the 
HMOX1 gene. Hou et al. (2012) found increased expression 
of Let-7 family members while Go et al. (2016) reported 
that miR-196a is able to repress Bach1, which allows 
increased HO-1-expression. Our results also suggest that 
the downregulation of miR-28 and miR-132, based on 
Yang et al. (2011) and Stachurska et al. (2013) findings 
might permit Nrf2 to increase and thereby activate HO 
expression. 
In our study, the H2S generating CSE enzyme expression 
was reduced and this effect might be explained by the 
upregulated miR-30 (Shen et al., 2015) and miR-186 (Yao 
et al., 2016) expressions, which target CSE’s 3’ UTR 
sequence and contribute to degradation of CSE mRNA. 
 
 
Conclusion 
 
Based on our results and on the current literature, we 
suggest several miRNAs, which might have a regulatory 
effect on gasotransmitter synthesizing enzymes: miR-26a, 
miR-21, miR-222, miR-200a, miR-200c, miR-101, miR-28, 
miR-132, miR-7, miR-141, Let-7, miR-196a, miR-186 and 
miR-30. Our results may indicate that miRNAs could serve 
as biomarkers for IBD, aiding early diagnosis and leading 
to the development of personalized therapies. 
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